| 1 |
Kopp RP, Stratton KL, Glogowski E, et al. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma[J]. Cancer, 2017, 123(13): 2452-2458.
|
| 2 |
Shingarev R, Jaimes EA. Renal cell carcinoma: new insights and challenges for a clinician scientist[J]. Am J Physiol Renal Physiol, 2017, 313(2):F145-F154.
|
| 3 |
Ni D, Ma X, Li HZ, et al. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma[J]. Clin Cancer Res, 2014, 20(7):1779-1790.
|
| 4 |
Kirwan A, Utratna M, O'dwyer ME, et al. Glycosylation-Based serum biomarkers for cancer diagnostics and prognostics[J]. Biomed Res Int, 2015:490531.
|
| 5 |
Liloglou T, Bediaga NG, Brown BR, et al. Epigenetic biomarkers in lung cancer[J]. Cancer Lett, 2014, 342(2, SI):200-212.
|
| 6 |
Mazzone PJ, Sears CR, Arenberg DA, et al. Evaluating molecular biomarkers for the early detection of lung cancer: when is a biomarker ready for clinical use? an official American thoracic society policy statement[J]. Am J Respir Crit Care Med, 2017, 196(7):e15-e29.
|
| 7 |
Khan MI, Dębski KJ, Dabrowski M, et al. Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line[J]. Am J Physiol Renal Physiol, 2016, 311(2):F424- F436.
|
| 8 |
Katheder NS, Khezri R, O'farrell F, et al. Microenvironmental autophagy promotes tumour growth[J]. Nature, 2017, 541(7637):417-420.
|
| 9 |
Horiguchi A, Sumitomo M, Asakuma J, et al. Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway[J]. J Urol, 2006, 176(4 Pt 1):1636-1641.
|
| 10 |
Pei X, Li M, Zhan J, et al. Enhanced IMP3 expression activates NF-кB pathway and promotes renal cell carcinoma progression[J]. PLoS One, 2015, 10(4):e0124338.
|
| 11 |
Zhu J, Cui L, Xu A, et al. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration[J]. BMC Cancer, 2017, 17(1):176.
|
| 12 |
Huang D, Ding Y, Zhou M, et al. Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma[J]. Cancer Res, 2010, 70(3):1063-1071.
|
| 13 |
Castaño-Rodríguez N, Kaakoush NO, Goh KL, et al. The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses[J]. PLoS One, 2014, 9(6):e98899.
|
| 14 |
Matušan-Ilijaš K, Damante G, Fabbro D, et al. EGFR expression is linked to osteopontin and Nf-kappaB signaling in clear cell renal cell carcinoma[J]. Clin Transl Oncol, 2013, 15(1):65-71.
|
| 15 |
Tsaur I, Noack A, Waaga-Gasser AM, et al. Chemokines involved in tumor promotion and dissemination in patients with renal cell cancer[J]. Cancer Biomark, 2011, 10(5):195-204.
|
| 16 |
Hardaway AL, Herroon MK, Rajagurubandara E, et al. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer[J]. Clin Exp Metastasis, 2015, 32(4):353-368.
|
| 17 |
Bachmeier BE, Mohrenz IV, Mirisola V, et al. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB[J]. Carcinogenesis, 2008, 29(4):779-789.
|
| 18 |
Mikami S, Mizuno R, Kosaka T, et al. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas[J]. Int J Cancer, 2015, 136(7):1504-1514.
|
| 19 |
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma[J]. Nature, 2013, 499(7456):43-49.
|
| 20 |
Kim DH, Wirtz D. Predicting how cells spread and migrate: focal adhesion size does matter[J]. Cell Adh Migr, 2013, 7(3):293-296.
|
| 21 |
Lin WC, Wang LC, Pang TL, et al. Actin-binding protein G (AbpG) participates in modulating the actin cytoskeleton and cell migration in Dictyostelium discoideum[J]. Mol Biol Cell, 2015, 26(6):1084-1097.
|